Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-20-000007

Chief Scientific Officer gave up 16,739 shares (to pay taxes)

  • Chief Scientific Officer acquired 47,467 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Humeau Laurent · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-03-05 Exercise or conversion : show line 1 in the form +27,567 77,900 D
2020-03-05 Shares withheld for taxes : show line 2 in the form −9,857 $9.80 $96,599 68,043 D
2020-03-08 Exercise or conversion : show line 3 in the form +19,900 87,943 D
2020-03-08 Shares withheld for taxes : show line 4 in the form −6,882 $14.09 $96,967 81,061 D

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2020-03-05 Exercise or conversion : show line 5 in the form Restricted Stock Unit −27,567 27,567 27,566 D
2020-03-08 Exercise or conversion : show line 6 in the form Restricted Stock Unit −19,900 19,900 39,800 D
Loading xslF345X03/wf-form4_158378499078811.xml…